Tizanidine
Product Images NDC 53217-211

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 53217-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-structure (Tizanidine Usp 1)

Chemical structure of Tizanidine hydrochloride, showing its ring systems and chlorine substitution, consistent with the active ingredient in the product Tizanidine by Aidarex Pharmaceuticals LLC.*

FDA Label Image

Tizanidine-figure1 (Tizanidine Usp 2)

A pharmacokinetic line graph showing plasma concentration of Tizanidine (ng/ml) over time (hours) after dosing. Four different curves compare 4 mg Tizanidine in tablet and capsule forms, both with and without food, illustrating plasma concentration changes up to 24 hours.*

FDA Label Image

Tizanidine-figure2 (Tizanidine Usp 3)

A line graph showing improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph includes error bars at each time point depicting variability.*

FDA Label Image

Tizanidine-figure3 (Tizanidine Usp 4)

A line chart depicting improvement in Ashworth Score over three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The chart compares Tizanidine (mean dose 28.8 mg) and placebo groups, showing data points with error bars indicating variability in improvement scores.*

FDA Label Image

Package Label (Tizanidine Usp 5)

Label for Tizanidine USP 4 mg tablets by Aidarex Pharmaceuticals LLC. The label states the package contains 30 tablets, generic for Zanaflex, with each tablet containing 4.576 mg of tizanidine hydrochloride equivalent to 4 mg base. The tablets are described as white round with scoring. The manufacturer is Alkaloida Chemical Company ZRT, Hungary.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.